Episode 12 – ELISA assays with Dr Ana Miletic and Anna Dey, Kyowa Kirin & Dr Cathy Olsen, Molecular Devices
Posted: 12 September 2022 | Drug Target Review | No comments yet
In this episode, experts discuss how they use ELISA assays in their research as well as the specific benefits of this kind of immunoassay.
In this podcast, in association with Molecular Devices, we cover ELISA assays, their advantages and automation with experts Dr Ana Miletic, Senior Research Scientist and Anna Dey, Senior Research Associate at Kyowa Kirin, as well as Dr Cathy Olsen, Senior Applications Scientist at Molecular Devices.
Listen now to discover how ELISA assays work, why they are highly sensitive and how they are used within our experts’ research, plus much more!
Key learning points:
- How ELISA assays can support a wide range of research in drug discovery and development
- Advantages of ELISA assays compared to other immunoassays
- What kind of instrumentation is used for ELISA assays and what elements of an automation platform are most critical for success
- What research directions have been opened up through the use of ELISAs.
Make sure you don’t miss any new podcasts from Drug Target Review – sign up here to be notified of releases!
Biomarkers aren’t just supporting drug discovery – they’re driving it
FREE market report
From smarter trials to faster insights, this report unpacks the science, strategy and real-world impact behind the next generation of precision therapies.
What you’ll unlock:
- How biomarkers are guiding dose selection and early efficacy decisions in complex trials
- Why multi-omics, liquid biopsy and digital tools are redefining the discovery process
- What makes lab data regulatory-ready and why alignment matters from day one
Explore how biomarkers are shaping early drug development
Access the full report – it’s free!
Dr Ana Miletic is a Senior Research Scientist in Discovery Research and Open Innovation at Kyowa Kirin. Ana received her PhD in Immunology from Washington University in St Louis and completed her postdoctoral training at Sanford Burnham Prebys Medical Discovery Institute. Before joining Kyowa Kirin, Ana worked at eBioscience and Becton Dickinson in discovery of monoclonal antibodies for research use. She was recognised as an HBA Rising Star in 2022.
Anna Dey is a Senior Research Associate at Kyowa Kirin. She has a BS in Zoology from Brigham Young University and a MS in Biotechnology from Johns Hopkins University. At Kyowa Kirin, she tests the efficacy of antibody therapeutics in in vitro functional assays. Earlier in her career, she worked in cancer research at Johns Hopkins University and Caliper Life Sciences.
Dr Cathy Olsen is a Senior Applications Scientist at Molecular Devices, where she develops a broad range of applications for microplate-based detection systems – including cell-based, biochemical and imaging assays. She has a PhD in Cell and Developmental Biology from the University of California, Davis.
Related topics
Antibodies, Assays, Drug Development, Drug Discovery, Immunoassays, Lab Automation
Related organisations
Kyowa Kirin, Molecular Devices
